Literature DB >> 22607964

Age-dependent prevalence of antibodies cross-reactive to the influenza A(H3N2) variant virus in sera collected in Norway in 2011.

K Waalen1, A Kilander, S G Dudman, R Ramos-Ocao, O Hungnes.   

Abstract

Antibody cross-reactivity to the influenza A(H3N2) variant virus recently reported in the United States, was investigated in Norwegian sera. Seroprevalence was 40% overall, and 71% in people born between 1977 and 1993. The most susceptible age groups were children and people aged around 50 years. The high immunity in young adults is likely to be due to strong priming infection with similar viruses in the 1990s. More research is needed to explain the poor immunity in 45–54 year-olds.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22607964

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  21 in total

1.  Recognition of influenza H3N2 variant virus by human neutralizing antibodies.

Authors:  Sandhya Bangaru; Travis Nieusma; Nurgun Kose; Natalie J Thornburg; Jessica A Finn; Bryan S Kaplan; Hannah G King; Vidisha Singh; Rebecca M Lampley; Gopal Sapparapu; Alberto Cisneros; Kathryn M Edwards; James C Slaughter; Srilatha Edupuganti; Lilin Lai; Juergen A Richt; Richard J Webby; Andrew B Ward; James E Crowe
Journal:  JCI Insight       Date:  2016-07-07

2.  Investigation of an Outbreak of Variant Influenza A(H3N2) Virus Infection Associated With an Agricultural Fair-Ohio, August 2012.

Authors:  Adena Greenbaum; Celia Quinn; Jennifer Bailer; Su Su; Fiona Havers; Lizette O Durand; Victoria Jiang; Shannon Page; Jeremy Budd; Michael Shaw; Matthew Biggerstaff; Sietske de Fijter; Kathleen Smith; Carrie Reed; Scott Epperson; Lynnette Brammer; Dave Feltz; Kevin Sohner; Jared Ford; Seema Jain; Paul Gargiullo; Edward Weiss; Pat Burg; Mary DiOrio; Brian Fowler; Lyn Finelli; Michael A Jhung
Journal:  J Infect Dis       Date:  2015-05-05       Impact factor: 5.226

3.  Transmissibility of variant influenza from Swine to humans: a modeling approach.

Authors:  Karen K Wong; Manoj Gambhir; Lyn Finelli; David L Swerdlow; Stephen Ostroff; Carrie Reed
Journal:  Clin Infect Dis       Date:  2013-07       Impact factor: 9.079

4.  Safety and Immunogenicity of Cell Culture-Derived A/H3N2 Variant Influenza Vaccines: A Phase I Randomized, Observer-Blind, Dose-Ranging Study.

Authors:  Casey Johnson; Matthew Hohenboken; Terry Poling; Peter Jaehnig; Niranjan Kanesa-Thasan
Journal:  J Infect Dis       Date:  2014-12-23       Impact factor: 5.226

5.  Effect of Priming With Seasonal Influenza A(H3N2) Virus on the Prevalence of Cross-Reactive Hemagglutination-Inhibition Antibodies to Swine-Origin A(H3N2) Variants.

Authors:  Feng Liu; Vic Veguilla; F Liaini Gross; Eric Gillis; Thomas Rowe; Xiyan Xu; Terrence M Tumpey; Jacqueline M Katz; Min Z Levine; Xiuhua Lu
Journal:  J Infect Dis       Date:  2017-09-15       Impact factor: 5.226

6.  Amino Acids in Hemagglutinin Antigenic Site B Determine Antigenic and Receptor Binding Differences between A(H3N2)v and Ancestral Seasonal H3N2 Influenza Viruses.

Authors:  Xiaoquan Wang; Natalia A Ilyushina; Vladimir Y Lugovtsev; Nicolai V Bovin; Laura K Couzens; Jin Gao; Raymond P Donnelly; Maryna C Eichelberger; Hongquan Wan
Journal:  J Virol       Date:  2017-01-03       Impact factor: 5.103

7.  Impact of prior seasonal H3N2 influenza vaccination or infection on protection and transmission of emerging variants of influenza A(H3N2)v virus in ferrets.

Authors:  Katherine V Houser; Melissa B Pearce; Jacqueline M Katz; Terrence M Tumpey
Journal:  J Virol       Date:  2013-10-02       Impact factor: 5.103

8.  Heterologous Antibody Responses Conferred by A(H3N2) Variant and Seasonal Influenza Vaccination Against Newly Emerged 2016-2018 A(H3N2) Variant Viruses in Healthy Persons.

Authors:  Feng Liu; Min Z Levine
Journal:  Clin Infect Dis       Date:  2020-12-15       Impact factor: 9.079

9.  Multiple contributory factors to the age distribution of disease cases: a modeling study in the context of influenza A(H3N2v).

Authors:  Manoj Gambhir; David L Swerdlow; Lyn Finelli; Maria D Van Kerkhove; Matthew Biggerstaff; Simon Cauchemez; Neil M Ferguson
Journal:  Clin Infect Dis       Date:  2013-07       Impact factor: 9.079

10.  H3N2v and other influenza epidemic risk based on age-specific estimates of sero-protection and contact network interactions.

Authors:  Danuta M Skowronski; Flavia S Moser; Naveed Z Janjua; Bahman Davoudi; Krista M English; Dale Purych; Martin Petric; Babak Pourbohloul
Journal:  PLoS One       Date:  2013-01-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.